The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial-Reference-Cited by-同舟云学术

The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: A randomized crossover clinical trial

Published:2011-01 Issue:1 Volume:69 Page:111-118
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Corvol Jean-Christophe,Bonnet Cécilia,Charbonnier-Beaupel Fanny,Bonnet Anne-Marie,Fiévet Marie-Hélène,Bellanger Agnès,Roze Emmanuel,Meliksetyan Gayané,Ben Djebara Mouna,Hartmann Andreas,Lacomblez Lucette,Vrignaud Cédric,Zahr Noël,Agid Yves,Costentin Jean,Hulot Jean-Sébastien,Vidailhet Marie

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.22155/fullpdf

Reference25 articles.

1. Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA;Fahn;Arch Neurol,1999

2. Medical management of levodopa-associated motor complications in patients with Parkinson's disease;Jankovic;CNS Drugs,2007

4. Pharmacokinetics of levodopa;Nutt;Clin Neuropharmacol,1984

5. New, selective catechol-O-methyltransferase inhibitors as therapeutic agents in Parkinson's disease;Bonifati;Pharmacol Ther,1999

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing the Ethnicity Gap in Catechol O-Methyl Transferase Inhibitor Trials in Parkinson’s Disease: A Review of Available Global Data;Journal of Personalized Medicine;2024-09-03

2. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach;Movement Disorders;2024-01-20

3. Association of catechol-O-methyltransferase gene polymorphisms with treatment response and levodopa-induced complications in Parkinson's disease: A summary of current knowledge;Arhiv za farmaciju;2024

4. The expanding role of gene-based prescribing for phase II drug-metabolizing enzymes;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2023-12-22

5. Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease;European Journal of Neurology;2023-10-15